YAROSLAV YANISHIN: Open Payments
NPI 1083127799 · GARDEN CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,871 in 114 payments from 16 companies in 2025. Trend: 2023 $2,336 · 2024 $3,166 · 2025 $2,871
Food & beverage: $2,573Education: $298
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $497 |
| Botanix SB Inc | 11 | $439 |
| Regeneron Healthcare Solutions, Inc. | 7 | $333 |
| GENZYME CORPORATION | 8 | $288 |
| ABBVIE INC. | 12 | $230 |
| Novartis Pharmaceuticals Corporation | 11 | $224 |
| PFIZER INC. | 10 | $183 |
| Incyte Corporation | 10 | $170 |
| E.R. Squibb & Sons, L.L.C. | 7 | $145 |
| Lilly USA, LLC | 9 | $119 |
Products named: DUPIXENT, TREMFYA, SOFDRA, COSENTYX, CIBINQO, OPZELURA, SKYRIZI, Sotyktu.
Industry payments across NY — which companies pay providers there.
